AIMS/HYPOTHESIS: Our goal was to identify a set of human adipose tissue macrophage (ATM)-specific markers and investigate whether their gene expression in subcutaneous adipose tissue (SAT) as well as in visceral adipose tissue (VAT) is related to obesity and to the occurrence of the metabolic syndrome. METHODS: ATM-specific markers were identified by DNA microarray analysis of adipose tissue cell types isolated from SAT of lean and obese individuals. We then analysed gene expression of these markers by reverse transcription quantitative PCR in paired samples of SAT and VAT from 53 women stratified into four groups (lean, overweight, obese and obese with the metabolic syndrome). Anthropometric measurements, euglycaemic-hyperinsulinaemic clamp, blood analysis and computed tomography scans were performed. RESULTS: A panel of 24 genes was selected as ATM-specific markers based on overexpression in ATM compared with other adipose tissue cell types. In SAT and VAT, gene expression of ATM markers was lowest in lean and highest in the metabolic syndrome group. mRNA levels in the two fat depots were negatively correlated with glucose disposal rate and positively associated with indices of adiposity and the metabolic syndrome. CONCLUSIONS/ INTERPRETATION: In humans, expression of ATM-specific genes increases with the degree of adiposity and correlates with markers of insulin resistance and the metabolic syndrome to a similar degree in SAT and in VAT.
AIMS/HYPOTHESIS: Our goal was to identify a set of human adipose tissue macrophage (ATM)-specific markers and investigate whether their gene expression in subcutaneous adipose tissue (SAT) as well as in visceral adipose tissue (VAT) is related to obesity and to the occurrence of the metabolic syndrome. METHODS: ATM-specific markers were identified by DNA microarray analysis of adipose tissue cell types isolated from SAT of lean and obese individuals. We then analysed gene expression of these markers by reverse transcription quantitative PCR in paired samples of SAT and VAT from 53 women stratified into four groups (lean, overweight, obese and obese with the metabolic syndrome). Anthropometric measurements, euglycaemic-hyperinsulinaemic clamp, blood analysis and computed tomography scans were performed. RESULTS: A panel of 24 genes was selected as ATM-specific markers based on overexpression in ATM compared with other adipose tissue cell types. In SAT and VAT, gene expression of ATM markers was lowest in lean and highest in the metabolic syndrome group. mRNA levels in the two fat depots were negatively correlated with glucose disposal rate and positively associated with indices of adiposity and the metabolic syndrome. CONCLUSIONS/ INTERPRETATION: In humans, expression of ATM-specific genes increases with the degree of adiposity and correlates with markers of insulin resistance and the metabolic syndrome to a similar degree in SAT and in VAT.
Authors: Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin Journal: J Lipid Res Date: 2005-09-08 Impact factor: 5.922
Authors: Javier Gómez-Ambrosi; Victoria Catalán; Alberto Diez-Caballero; L Alfonso Martinez-Cruz; María J Gil; Jesús García-Foncillas; Javier A Cienfuegos; Javier Salvador; José M Mato; Gema Frühbeck Journal: FASEB J Date: 2003-11-20 Impact factor: 5.191
Authors: Joakim Huber; Florian W Kiefer; Maximilian Zeyda; Bernhard Ludvik; Gerd R Silberhumer; Gerhard Prager; Gerhard J Zlabinger; Thomas M Stulnig Journal: J Clin Endocrinol Metab Date: 2008-05-20 Impact factor: 5.958
Authors: Emilio Ortega Martinez de Victoria; Xiaoyuan Xu; Juraj Koska; Ann Marie Francisco; Michael Scalise; Anthony W Ferrante; Jonathan Krakoff Journal: Diabetes Date: 2008-11-13 Impact factor: 9.461
Authors: Xuezheng Sun; Patricia Casbas-Hernandez; Carol Bigelow; Liza Makowski; D Joseph Jerry; Sallie Smith Schneider; Melissa A Troester Journal: Breast Cancer Res Treat Date: 2011-10-15 Impact factor: 4.872
Authors: Derek K Hagman; Ilona Larson; Jessica N Kuzma; Gail Cromer; Karen Makar; Katya B Rubinow; Karen E Foster-Schubert; Brian van Yserloo; Peter S Billing; Robert W Landerholm; Matthew Crouthamel; David R Flum; David E Cummings; Mario Kratz Journal: Metabolism Date: 2017-02-02 Impact factor: 8.694
Authors: Dongmei Liu; Flor Elisa Morales; Heidi B IglayReger; Mary K Treutelaar; Amy E Rothberg; Monica J Hubal; Evan P Nadler; Jacques Robidoux; Hisham Barakat; Jeffrey F Horowitz; Eric P Hoffman; Charles F Burant; Paul M Gordon Journal: Appl Physiol Nutr Metab Date: 2017-10-16 Impact factor: 2.665
Authors: I P G Van Bussel; E M P Backx; C P G M De Groot; M Tieland; M Müller; L A Afman Journal: Int J Obes (Lond) Date: 2017-03-24 Impact factor: 5.095
Authors: Wilfredo Oliva-Olivera; Antonio Leiva Gea; Said Lhamyani; Leticia Coín-Aragüez; Juan Alcaide Torres; Maria Rosa Bernal-López; Pedro Pablo García-Luna; Salvador Morales Conde; Sonia Fernández-Veledo; Rajaa El Bekay; Francisco José Tinahones Journal: Endocrinology Date: 2015-09-15 Impact factor: 4.736
Authors: Alejandro A Diaz; Tom P Young; Sila Kurugol; Erick Eckbo; Nina Muralidhar; Joshua K Chapman; Gregory L Kinney; James C Ross; Raul San Jose Estepar; Rola Harmouche; Jennifer L Black-Shinn; Matthew Budoff; Russell P Bowler; John Hokanson; George R Washko Journal: Chronic Obstr Pulm Dis Date: 2015
Authors: Martin Torriani; Markella V Zanni; Kathleen Fitch; Eleni Stavrou; Miriam A Bredella; Ruth Lim; Aaron M Cypess; Steven Grinspoon Journal: Antivir Ther Date: 2012-10-05